Expression of fibroblast growth factor 9 is associated with poor prognosis in patients with resected non-small cell lung cancerKeiko Ohgino, Tomoko Betsuyaku, Shinnosuke Ikemura et al.|Lung Cancer|2013Cited by 49
Abstract 5652: Activation of FGF2-FGFR1 pathway in EGFR-mutant lung cancer cell line with long-term gefitinib exposure.Hideki Terai, Tomoko Betsuyaku, Kenzo Soejima et al.|Cancer Research|2013Cited by 0
Abstract 5195: Claudin-1, a novel target of miR-375 in non-small cell lung cancerSatoshi Yoda, Tomoko Betsuyaku, Kenzo Soejima et al.|Cancer Research|2014Cited by 0
Abstract 5257: FGF9 overexpression promotes tumorigenic potential of non-small cell lung cancer (NSCLC) cells, and is associated with poor prognosis in NSCLC patients.Kota Ishioka, Tomoko Betsuyaku, Kenzo Soejima et al.|Cancer Research|2013Cited by 0
Abstract 3006: Hyperoxia may be a treatment option for NSCLCJunko Hamamoto, Kenzo Soejima, Hiroyuki Yasuda et al.|Cancer Research|2015Cited by 0